# The Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994, Paragraph 20


In the Medicines (Advertising) Regulations 1994—
(a) in paragraph (1) of regulation 2, after the definition of “essential information” there shall be inserted the following definition—
““marketing authorization” means a marketing authorization granted by the European Commission under Council Regulation (EEC) No. 2309/93 or by the licensing authority under the Medicines for Human Use (Marketing Authorizations Etc.) Regulations 1994 and includes a product licence granted by the licensing authority under Part II of the Act;”;
(b) in paragraph (1) of regulation 3, for the words “product licence” there shall be substituted the words “marketing authorization”; and
(c) in regulation 4 for the words “product licence” there shall be substituted the words “marketing authorization”;
(d) in sub-paragraph (l) of paragraph (1) of regulation 9, for the words “product licence” there shall be substituted the words “marketing authorization”;
(e) in regulation 12, for the words “product licence” there shall be substituted the words “marketing authorization”; and
(f) in Schedule 2—
(i) in paragraph 1, for the word “licence” there shall be substituted the word “authorization”;
(ii) in paragraph 2, for the words “product licence” there shall be substituted the words “marketing authorization”; and
(iii) in paragraph 5, for the word “licence” there shall be substituted the word “authorization”; and

---
Source: https://www.legislation.gov.uk/uksi/1994/3144/schedule/7/paragraph/20 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-marketing-authorisations-etc-regulations-1994/schedule-7/paragraph-20
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.